EE9400337A - Pharmaceutical compositions containing interferon alpha and their uses - Google Patents

Pharmaceutical compositions containing interferon alpha and their uses

Info

Publication number
EE9400337A
EE9400337A EE9400337A EE9400337A EE9400337A EE 9400337 A EE9400337 A EE 9400337A EE 9400337 A EE9400337 A EE 9400337A EE 9400337 A EE9400337 A EE 9400337A EE 9400337 A EE9400337 A EE 9400337A
Authority
EE
Estonia
Prior art keywords
pharmaceutical compositions
compositions containing
interferon alpha
containing interferon
alpha
Prior art date
Application number
EE9400337A
Other languages
Estonian (et)
Inventor
J. Spiegel Robert
M. Cuss Francis
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of EE9400337A publication Critical patent/EE9400337A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
EE9400337A 1990-12-14 1994-11-21 Pharmaceutical compositions containing interferon alpha and their uses EE9400337A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62824090A 1990-12-14 1990-12-14

Publications (1)

Publication Number Publication Date
EE9400337A true EE9400337A (en) 1996-02-15

Family

ID=24518070

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400337A EE9400337A (en) 1990-12-14 1994-11-21 Pharmaceutical compositions containing interferon alpha and their uses

Country Status (11)

Country Link
EP (1) EP0563177A1 (en)
JP (1) JPH06503570A (en)
AU (1) AU9139091A (en)
CA (1) CA2098393A1 (en)
EE (1) EE9400337A (en)
IE (1) IE914326A1 (en)
IL (1) IL100332A0 (en)
MX (1) MX9102512A (en)
PT (1) PT99784A (en)
WO (1) WO1992010207A1 (en)
ZA (1) ZA919769B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9213322D0 (en) * 1992-06-23 1992-08-05 Efamol Holdings Antioxidant compositions
EP1104809A1 (en) * 1994-04-09 2001-06-06 F. Hoffmann-La Roche Ag Process for producing alpha-interferon
US6207145B1 (en) 1997-05-09 2001-03-27 Pharma Pacific Pty Ltd. Therapeutic applications of high dose interferon
CN1151840C (en) * 1996-05-09 2004-06-02 太平洋制药控股公司 Stimulation of host defence mechanisms against tumors
CA2253971A1 (en) 1996-05-09 1997-11-13 Pharma Pacific Pty.Ltd. Use of high dose interferon by oralmucosal contact to treat viral infections and neoplastic conditions
AUPN976596A0 (en) * 1996-05-09 1996-05-30 Pharma Pacific Pty Ltd Stimulation of host defence mechanisms
US6660258B1 (en) 1997-05-09 2003-12-09 Pharma Pacific Pty Ltd Oromucosal cytokine compositions and uses thereof
AU2002330801A1 (en) * 2002-06-20 2004-01-06 Igor Anatolievich Pomytkin Method for oral transmucosal delivery of interferon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0305551A3 (en) * 1981-10-13 1990-01-10 Exovir, Inc. Pharmaceutical compositions for topical application
ZA899113B (en) * 1988-12-01 1990-08-29 Schering Corp Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon

Also Published As

Publication number Publication date
JPH06503570A (en) 1994-04-21
PT99784A (en) 1992-12-31
WO1992010207A1 (en) 1992-06-25
MX9102512A (en) 1992-06-01
ZA919769B (en) 1992-09-30
CA2098393A1 (en) 1992-06-15
AU9139091A (en) 1992-07-08
IE914326A1 (en) 1992-06-17
IL100332A0 (en) 1992-09-06
EP0563177A1 (en) 1993-10-06

Similar Documents

Publication Publication Date Title
BR1100824A (en) Pharmaceutical composition and composition
DE3486441T2 (en) 3-hydroxypyrid-4-one and pharmaceutical compositions
EE03108B1 (en) Pharmaceutical composition
FI981777A (en) Pharmaceutical composition
DK1023900T3 (en) Pharmaceutical composition containing S-nitroso-lipoproteins and use thereof
PT589843E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORTS
HU9802116D0 (en) 19-nor-d-vitamin compounds with biologically effect and pharmaceutical compositions containing them
MX9202839A (en) 4-AMINOKINOLINS AND PHARMACEUTICAL COMPOSITIONS OF THE SAME.
DE10199066I1 (en) Pharmaceutical composition
BR9200058A (en) PHARMACEUTICAL COMPOUND AND COMPOSITION
ITRM910952A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING GONADATROPINES
MX9200622A (en) PHARMACEUTICAL COMPOSITION
IL97122A0 (en) Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them
MX9101035A (en) BIOLOGICALLY ACTIVE QUINAZOLINONES AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM
DE4294862T1 (en) Pharmaceutical composition
KR890016965A (en) Antibiotic compositions and uses thereof
EE9400337A (en) Pharmaceutical compositions containing interferon alpha and their uses
UA26064A1 (en) PHARMACEUTICAL COMPOSITION
KR900012897A (en) Guanidine derivatives and pharmaceutical compositions containing them
IT9020144A0 (en) PHARMACEUTICAL COMPOSITION CONTAINING EGF
BR8905444A (en) COMPOSITIONS AND APPLICATION
FI934387A0 (en) 3-SUBSTITUTES 2-OXI-INDOL-1-CARBOXIAMIDE PHARMACEUTICAL COMPOSITION
FI920845A (en) PHARMACEUTICAL COMPOSITION INNEHAOLLANDE INTERLEUKIN-2
BR1100486A (en) Pharmaceutical composition and composition
ITMI912766A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CISTEIN